Home Drug Infusion Therapy Under Medicare

Power, Elaine J.

doi:10.1001/jama.1993.03510040027008

JAMA

1993

DOI: 10.1001/jama.1993.03510040027008

|View full text |Cite

Home Drug Infusion Therapy Under Medicare

Elaine J. Power¹

Abstract: Table l-2-issues and Options for Covering Home Drug Infusion Therapy (HDIT) Under Medicare Basic Issue: Should Medicare cover HDIT? Option O: Enact a home drug infusion benefit under Medicare.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1995

2010

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Update and Overview of Outpatient Parenteral Antimicrobial Therapy Regulations and Reimbursement

Nolet¹

2010

CLIN INFECT DIS

View full text Add to dashboard Cite

Outpatient care, including outpatient parenteral antimicrobial therapy (OPAT), is increasingly seen by both clinicians and insurers as a safe, effective, and economical adjunct or alternative to hospitalization. Despite this, perhaps the least understood reimbursement and regulatory policies for health care services are those that apply to OPAT. We present a brief review and update of current rules and regulations relating to OPAT, with emphasis on areas of special interest to physicians serving as medical directors of home or ambulatory infusion programs or providing OPAT as an extension of their office practices.

show abstract

Update and Overview of Outpatient Parenteral Antimicrobial Therapy Regulations and Reimbursement

Nolet¹

2010

CLIN INFECT DIS

View full text Add to dashboard Cite

show abstract

A Managed Care Model for Home Infusion Therapy

et al. 1995

View full text Add to dashboard Cite

Home infusion therapy began in response to the medical needs of the patients. In the traditional model, products and services were delivered in the home on a physician's prescription. Limitations related to medical quality management and cost were recognized in this model. Because of these limitations, the changes that continue to occur in health care delivery and the increase in number and acuity of patients requiring non-hospital services, a managed care model was conceived and implemented at the University of Minnesota Medical School and Hospital. This model emphasizes physician-based case management, total quality management, a point of contact medical information system, outcomes assessment and management, and research and education activities designed to evaluate and improve home infusion therapies. The model was implemented through a public-private partnership. This application of managed care to home infusion therapies is described in this communication.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Home Drug Infusion Therapy Under Medicare

Abstract: Table l-2-issues and Options for Covering Home Drug Infusion Therapy (HDIT) Under Medicare Basic Issue: Should Medicare cover HDIT? Option O: Enact a home drug infusion benefit under Medicare.

Cited by 2 publications

References 61 publications

Update and Overview of Outpatient Parenteral Antimicrobial Therapy Regulations and Reimbursement

Update and Overview of Outpatient Parenteral Antimicrobial Therapy Regulations and Reimbursement

A Managed Care Model for Home Infusion Therapy

Contact Info

Product

Resources

About